Skip to content
DataLookout
Menu

NCT07324512

Minimum Effective Volume of Crystalloid Co-Loading to Prevent Spinal Anesthesia-Induced Hypotension in Cesarean Section

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 31, 2026 to May 31, 2027 Show 6 more changesShow less
    • Recruitment opened
    • Primary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
    • Study completion pushed from Jun 30, 2026 to Jun 30, 2027
    • Start date changed from estimate of Dec 27, 2025 to Jan 11, 2026
    • Secondary endpoints: details revised at 14 of 15 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Minimum Effective Volume (MEV90) of Intravenous Crystalloid Co-Loading (mL/kg)
Timeframe: From intrathecal injection (start of spinal anesthesia) to end of surgery

Secondary (15)

Incidence of intraoperative hypotension (mmHg)
Incidence of intraoperative hypertension (mmHg)
Additional bolus phenylephrine requirement
Total Phenylephrine Dose (µg)
Estimated blood loss (mL)
Show 10 moreShow less
Incidence of Maternal Nausea Associated With Hypotension
Incidence of Maternal Vomiting Associated With Hypotension
Incidence of Maternal Dizziness/Lightheadedness Associated With Hypotension
Neonatal Apgar score at 1Minute
Neonatal Apgar Score at 5 Minutes
Umbilical Arterial pH
Umbilical Arterial Base Excess (mmol/L)
Pulmonary edema
Clinically Significant Generalized Edema
Acute Heart Failure

Arms and interventions

Crystalloid Co-LoadingExperimental

Participants undergo spinal anesthesia for elective cesarean delivery. Immediately after intrathecal injection, a predefined volume of balanced crystalloid (co-loading) is infused over \~10 minutes while a prophylactic phenylephrine infusion is initiated per protocol. The crystalloid volume for each successive participant is adjusted using a biased-coin up-and-down algorithm to identify the minimum effective volume that prevents spinal-anesthesia-induced hypotension in ≥90% of patients (MEV90, mL/kg). Blood pressure is monitored frequently; rescue phenylephrine and/or fluids are permitted to maintain predefined blood pressure ranges. Maternal adverse events and neonatal outcomes are recorded through postoperative day 2.

Other: Intravenous Crystalloid Co-Loading

Sites

1 site in 1 country

  • Seoul National University HospitalSeoul, South Korea